This year has been challenging for the stock market due to several macroeconomic and geopolitical issues. However, the market’s downtrend has created several opportunities to invest in quality stocks at attractive valuations.
Bristol-Myers Squibb Company (BMY) is one such stock investors could consider buying for solid long-term returns. The company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.
